David Fenwick has been part of the Chemistry Department at John Abbott College since 2004. He is a graduate of McGill University (B.Sc. Hons., 1998) and The University of British Columbia (M.Sc., 2002). Before his appointment at John Abbott College, David was part of the medicinal chemistry team at Aegera Therapeutics Inc., a private biotechnology firm specializing in apoptosis.